Release Date: 29/10/10 12:19 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 30.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%